AB0445 Exposure–Efficacy Analysis of Mavrilimumab in Rheumatoid Arthritis: Modeling and Simulation of Phase II Clinical Data
Jin, D.C., Wu, C.-Y., Roskos, L.K., Godwood, A., Close, D., Wang, B.Volume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2015-eular.4241
Date:
June, 2015
File:
PDF, 110 KB
english, 2015